Cargando…

Impact of Genetic Ancestry on Prognostic Biomarkers in Uveal Melanoma

SIMPLE SUMMARY: Genomic prognostic biomarkers play an important role in the application of precision medicine in patients with uveal melanoma (UM). In this study, we performed a pilot study to assess the impact of global and local genetic ancestry on the presence of these prognostic biomarkers. We f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rodriguez, Daniel A., Sanchez, Margaret I., Decatur, Christina L., Correa, Zelia M., Martin, Eden R., Harbour, J. William
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7693692/ https://www.ncbi.nlm.nih.gov/pubmed/33142712 http://dx.doi.org/10.3390/cancers12113208

Ejemplares similares

PRAME induces genomic instability in uveal melanoma
por: Kurtenbach, Stefan, et al.
Publicado: (2023)

Genomic evolution of uveal melanoma arising in ocular melanocytosis
por: Durante, Michael A., et al.
Publicado: (2019)

BAP1 Loss Promotes Suppressive Tumor Immune Microenvironment via Upregulation of PROS1 in Class 2 Uveal Melanomas
por: Kaler, Christopher J., et al.
Publicado: (2022)

Single-cell analysis reveals new evolutionary complexity in uveal melanoma
por: Durante, Michael A., et al.
Publicado: (2020)

Punctuated evolution of canonical genomic aberrations in uveal melanoma
por: Field, Matthew G., et al.
Publicado: (2018)

Clinical application of genetic testing for posterior uveal melanoma
por: Schopper, Victoria J., et al.
Publicado: (2016)

Multiregional genetic evolution of metastatic uveal melanoma
por: Rodriguez, Daniel A., et al.
Publicado: (2021)

Posterior uveal melanoma in adolescents and children: current perspectives
por: Fry, Matthew V, et al.
Publicado: (2018)

Sufficiency of FNAB aspirates of posterior uveal melanoma for cytologic versus GEP classification in 159 patients, and relative prognostic significance of these classifications
por: Correa, Zelia M., et al.
Publicado: (2013)

Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas
por: Field, Matthew G., et al.
Publicado: (2016)

The role of c-kit and imatinib mesylate in uveal melanoma
por: Pereira, Patricia Rusa, et al.
Publicado: (2005)

GNQ-209P Mutation in Metastatic Uveal Melanoma and Treatment Outcome
por: Abdel Karim, Nagla, et al.
Publicado: (2018)

Blood Biomarkers of Uveal Melanoma: Current Perspectives
por: Bande Rodríguez, Manuel F, et al.
Publicado: (2020)

Early treatment and toxicity outcomes for small posterior uveal melanomas treated using custom loaded eye plaques
por: Medek, Sara, et al.
Publicado: (2023)

Corrigendum to “Nivolumab and Ipilimumab in the Treatment of Metastatic Uveal Melanoma: A Single-Center Experience”
por: Karivedu, Vidhya, et al.
Publicado: (2019)

Prognostic value of legumain in uveal melanoma
por: WU, TONG, et al.
Publicado: (2016)

The DecisionDx-UM Gene Expression Profile Test Provides Risk Stratification and Individualized Patient Care in Uveal Melanoma
por: Harbour, J. William, et al.
Publicado: (2013)

Microincisional vitrectomy for retinal detachment in I-125 brachytherapy-treated patients with posterior uveal malignant melanoma
por: Lonngi, Marcela, et al.
Publicado: (2013)

MMP1 and MMP9 are potential prognostic biomarkers and targets for uveal melanoma
por: Wang, Tianyu, et al.
Publicado: (2021)

CARD11 is a prognostic biomarker and correlated with immune infiltrates in uveal melanoma
por: Shi, Xueying, et al.
Publicado: (2021)

Identification of Six Autophagy-Related-lncRNA Prognostic Biomarkers in Uveal Melanoma
por: Chen, Yao, et al.
Publicado: (2021)

Prognostic Biomarkers in Uveal Melanoma: The Status Quo, Recent Advances and Future Directions
por: Lamas, Nuno Jorge, et al.
Publicado: (2021)

Prognostic Hematologic Biomarkers Following Immune Checkpoint Inhibition in Metastatic Uveal Melanoma
por: Waninger, Jessica J., et al.
Publicado: (2022)

BAP1 deficiency causes loss of melanocytic cell identity in uveal melanoma
por: Matatall, Katie A, et al.
Publicado: (2013)

The genetics of uveal melanoma: current insights
por: Helgadottir, Hildur, et al.
Publicado: (2016)

The genetic evolution of metastatic uveal melanoma
por: Shain, A. Hunter, et al.
Publicado: (2019)

Genetics and RNA Regulation of Uveal Melanoma
por: Barbagallo, Cristina, et al.
Publicado: (2023)

Identification of prognostic genes in uveal melanoma microenvironment
por: Luo, Huan, et al.
Publicado: (2020)

EMT-associated factors promote invasive properties of uveal melanoma cells
por: Asnaghi, Laura, et al.
Publicado: (2015)

Psychosocial impact of prognostic genetic testing in uveal melanoma patients: a controlled prospective clinical observational study
por: Lieb, Marietta, et al.
Publicado: (2020)

Uveal Melanoma
por: Papastefanou, Vasilios P., et al.
Publicado: (2011)

Uveal Melanoma
por: Pfeffer, Ulrich
Publicado: (2019)

HDAC11 activity contributes to MEK inhibitor escape in uveal melanoma
por: Sriramareddy, Sathya Neelature, et al.
Publicado: (2022)

Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma
por: Harbour, J. William, et al.
Publicado: (2013)

Ischemia Is Related to Tumour Genetics in Uveal Melanoma
por: Brouwer, Niels J., et al.
Publicado: (2019)

Genetic Landscape and Emerging Therapies in Uveal Melanoma
por: Seedor, Rino S., et al.
Publicado: (2021)

Genetics of Uveal Melanoma and Cutaneous Melanoma: Two of a Kind?
por: van den Bosch, Thomas, et al.
Publicado: (2010)

Gamma knife radiosurgery for the treatment of uveal melanoma and uveal metastases
por: Reynolds, Margaret M., et al.
Publicado: (2017)

Using risk factors for detection and prognostication of uveal melanoma
por: Rishi, Pukhraj, et al.
Publicado: (2015)

Prognostic significance of deregulated microRNAs in uveal melanomas
por: Falzone, Luca, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_k5qfeflbo8udrjd414gcr0knkt